Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;28:153-158

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kato, H.
Right arrow Articles by Brecher, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kato, H.
Right arrow Articles by Brecher, P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ARGININE
*LOSARTAN POTASSIUM

(Hypertension. 1996;28:153-158.)
© 1996 American Heart Association, Inc.


Articles

Effects of Angiotensin II Infusion and Inhibition of Nitric Oxide Synthase on the Rat Aorta

Hiroshi Kato; Jian Hou; Aram V. Chobanian; Peter Brecher

the Department of Biochemistry and the Cardiovascular Institute, Boston (Mass) University School of Medicine.

Correspondence to Peter Brecher, PhD, Boston University School of Medicine, 80 E Concord St, Boston, MA 02118.

In previous studies, we showed that in vivo infusion of angiotensin II (Ang II) to adult rats induced vascular changes in gene expression, and this effect did not depend solely on blood pressure elevation. To determine whether nitric oxide can influence the effects of Ang II on the vessel wall, we administered to rats Ang II separately or in combination with the arginine analogue N{omega}-nitro-L-arginine methyl ester, which inhibits nitric oxide synthase chronically when given in vivo. We measured changes in aortic medial thickness, the association of macrophages with the endothelial surface of the aorta, the presence of proliferating cell nuclear antigen in the intima and adventitia as an index of aortic cell cycle changes, and the expression of immunodetectable fibronectin as an index of changes in the extracellular matrix. After 18 days of nitric oxide inhibition, the major changes were increased medial thickness and a 3.5-fold increase in the number of adherent macrophages. Rats treated with two different doses of Ang II for 3 days had a fivefold and threefold increase in the number of proliferating cells from the intimal and adventitial regions, respectively. Combined treatment resulted in increased medial thickness, intimal and adventitial cell proliferation, and macrophage adherence. An increased and altered pattern of fibronectin distribution was found in all treatment groups. Losartan administration prevented the effects of Ang II but not of nitric oxide inhibition, whereas administration of L-arginine prevented both intimal macrophage adherence and increased adventitial proliferation in rats given combined treatment. The data suggest that nitric oxide selectively influences macrophage association with the arterial wall, whereas Ang II and nitric oxide may have opposing effects on arterial cell proliferation.


Key Words: angiotensin II • nitric oxide • rats • aorta • hypertension, experimental • immunohistochemistry




This article has been cited by other articles:


Home page
HypertensionHome page
C. Bouvet, L.-A. Gilbert, D. Girardot, D. deBlois, and P. Moreau
Different Involvement of Extracellular Matrix Components in Small and Large Arteries During Chronic NO Synthase Inhibition
Hypertension, March 1, 2005; 45(3): 432 - 437.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Higashi, H. Shimokawa, T. Hattori, J. Hiroki, Y. Mukai, K. Morikawa, T. Ichiki, S. Takahashi, and A. Takeshita
Long-Term Inhibition of Rho-Kinase Suppresses Angiotensin II-Induced Cardiovascular Hypertrophy in Rats In Vivo: Effect on Endothelial NAD(P)H Oxidase System
Circ. Res., October 17, 2003; 93(8): 767 - 775.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Haider, I. Lee, J. Grabarek, Z. Darzynkiewicz, and N. R. Ferreri
Dual Functionality of Cyclooxygenase-2 as a Regulator of Tumor Necrosis Factor-Mediated G1 Shortening and Nitric Oxide-Mediated Inhibition of Vascular Smooth Muscle Cell Proliferation
Circulation, August 26, 2003; 108(8): 1015 - 1021.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. M.A.C. Martens, B. Demeilliers, D. Girardot, C. Daigle, H. H. Dao, D. deBlois, and P. Moreau
Vessel-Specific Stimulation of Protein Synthesis by Nitric Oxide Synthase Inhibition: Role of Extracellular Signal-Regulated Kinases 1/2
Hypertension, January 1, 2002; 39(1): 16 - 21.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Osanai, N. Akutsu, N. Fujita, T. Nakano, K. Takahashi, W. Guan, and K. Okumura
Cross talk between prostacyclin and nitric oxide under shear in smooth muscle cell: role in monocyte adhesion
Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H177 - H182.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Gu, J. Lynch, and P. Brecher
Nitric Oxide Increases p21Waf1/Cip1 Expression by a cGMP-dependent Pathway That Includes Activation of Extracellular Signal-regulated Kinase and p70S6k
J. Biol. Chem., April 6, 2000; 275(15): 11389 - 11396.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Usui, K. Egashira, H. Tomita, M. Koyanagi, M. Katoh, H. Shimokawa, M. Takeya, T. Yoshimura, K. Matsushima, and A. Takeshita
Important Role of Local Angiotensin II Activity Mediated via Type 1 Receptor in the Pathogenesis of Cardiovascular Inflammatory Changes Induced by Chronic Blockade of Nitric Oxide Synthesis in Rats
Circulation, January 25, 2000; 101(3): 305 - 310.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Gu and P. Brecher
Nitric Oxide-Induced Increase in p21Sdi1/Cip1/Waf1 Expression During the Cell Cycle in Aortic Adventitial Fibroblasts
Arterioscler Thromb Vasc Biol, January 1, 2000; 20(1): 27 - 34.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Osanai, N. Fujita, N. Fujiwara, T. Nakano, K. Takahashi, W. Guan, and K. Okumura
Cross talk of shear-induced production of prostacyclin and nitric oxide in endothelial cells
Am J Physiol Heart Circ Physiol, January 1, 2000; 278(1): H233 - H238.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Usui, K. Egashira, S. Kitamoto, M. Koyanagi, M. Katoh, C. Kataoka, H. Shimokawa, and A. Takeshita
Pathogenic Role of Oxidative Stress in Vascular Angiotensin-Converting Enzyme Activation in Long-Term Blockade of Nitric Oxide Synthesis in Rats
Hypertension, October 1, 1999; 34(4): 546 - 551.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Z. Cao, R. Dean, L. Wu, D. Casley, and M. E. Cooper
Role of Angiotensin Receptor Subtypes in Mesenteric Vascular Proliferation and Hypertrophy
Hypertension, September 1, 1999; 34(3): 408 - 414.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J.-A. Haefliger, P. Meda, A. Formenton, P. Wiesel, A. Zanchi, H. R. Brunner, P. Nicod, and D. Hayoz
Aortic Connexin43 Is Decreased During Hypertension Induced by Inhibition of Nitric Oxide Synthase
Arterioscler Thromb Vasc Biol, July 1, 1999; 19(7): 1615 - 1622.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Nicoletti and J.-B. Michel
Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors
Cardiovasc Res, March 1, 1999; 41(3): 532 - 543.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Gollasch, G. C. Wellman, H. J. Knot, J. H. Jaggar, D. H. Damon, A. D. Bonev, and M. T. Nelson
Ontogeny of Local Sarcoplasmic Reticulum Ca2+ Signals in Cerebral Arteries : Ca2+ Sparks as Elementary Physiological Events
Circ. Res., November 30, 1998; 83(11): 1104 - 1114.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Katoh, K. Egashira, M. Usui, T. Ichiki, H. Tomita, H. Shimokawa, H. Rakugi, and A. Takeshita
Cardiac Angiotensin II Receptors Are Upregulated by Long-Term Inhibition of Nitric Oxide Synthesis in Rats
Circ. Res., October 5, 1998; 83(7): 743 - 751.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Luvara, M. E. Pueyo, M. Philippe, C. Mandet, F. Savoie, D. Henrion, and J.-B. Michel
Chronic Blockade of NO Synthase Activity Induces a Proinflammatory Phenotype in the Arterial Wall : Prevention by Angiotensin II Antagonism
Arterioscler Thromb Vasc Biol, September 1, 1998; 18(9): 1408 - 1416.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. B. Parker, S. S. Wade, and R. L. Prewitt
Pressure Mediates Angiotensin II–Induced Arterial Hypertrophy and PDGF-A Expression
Hypertension, September 1, 1998; 32(3): 452 - 458.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. Moreau, H. Takase, L. V. d'Uscio, T. F. Luscher, and G. L. Baumbach
Effect of Chronic Nitric Oxide Deficiency on Angiotensin II–Induced Hypertrophy of Rat Basilar Artery • Editorial Comment
Stroke, May 1, 1998; 29(5): 1031 - 1036.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. J. Pagano, J. K. Clark, M. E. Cifuentes-Pagano, S. M. Clark, G. M. Callis, and M. T. Quinn
Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: Enhancement by angiotensin II
PNAS, December 23, 1997; 94(26): 14483 - 14488.
[Abstract] [Full Text] [PDF]